Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
LumiThera, Inc. logo — Valeda is FDA Authorized in the US, CE Marked in the EU, and...

LumiThera, Inc.

Valeda is FDA Authorized in the US, CE Marked in the EU, and available in select countries in Latin America.

Founded 2013 United States Poulsbo, United States 34 employees Series Unknown Total: $27.43M Health Care, Manufacturing +1

General Information

Company Name LumiThera, Inc.
Founded Year 2013
Location United States Poulsbo, United States +1
Founders / Decision Makers
Team member
Employees 34
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Series Unknown
Social

Get notified when LumiThera, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LumiThera, Inc.

LumiThera, Inc. is a United States-based startup focused on developing therapies for degenerative eye diseases using Photobiomodulation. The company's flagship product, the Valeda® Light Delivery System, utilizes multiwavelength photobiomodulation to treat dry age-related macular degeneration (AMD). While CE Marked in the EU and available in select Latin American countries, it is not cleared by the Food & Drug Administration (FDA) in the USA. Additionally, their AdaptDx Pro® dark adaptation functional testing technology allows early detection and monitoring of AMD, and the Diopsys® ERG and VEP systems aid in analyzing visual and neuro-visual disorders. The last recorded investment for LumiThera was a significant $2.43M Venture Round investment on May 21, 2024. As the company continues to advance its innovative light-based solutions in the healthcare and manufacturing industries, it presents an intriguing opportunity for venture capital firms seeking to support groundbreaking technologies addressing critical medical needs.

Taxonomy: photobiomodulation, ophthalmology, non-invasive treatments, dry age-related macular degeneration, clinical trials, vision improvement, eye diseases, innovation, CE Mark, European market, non-invasive medical treatments, Valeda Light Delivery System, clinical studies, light emitting diodes

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 21 May 2024
Debt Financing •••••• 3
Investor Investor
•••• •••• 		10 Mar 2022
Series C •••••• 4
Investor Investor Investor
•••• •••• 		08 Jul 2020
Series B •••••• 3
Investor
•••• •••• 		31 Oct 2017
Venture Round •••••• 1
Investor
01 Dec 2016

View All 6 Funding Rounds

FAQ About LumiThera, Inc.

Valeda is FDA Authorized in the US, CE Marked in the EU, and available in select countries in Latin America.
LumiThera, Inc. was founded in 2013.
LumiThera, Inc. is headquartered in Poulsbo, United States.
LumiThera, Inc. operates in the following industries: Health Care, Manufacturing, Medical Devices.
LumiThera, Inc. has approximately 34 employees.
LumiThera, Inc. has completed 6 funding rounds, raising a total of $27.43M. The latest funding stage is Series Unknown.

We're actively collecting intelligence on LumiThera, Inc..

Track LumiThera, Inc. to get notified

Don't just browse. Track.

Signal Tracker monitors LumiThera, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy